Literature DB >> 2443488

The hyaluronate receptor is identical to a glycoprotein of Mr 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity.

C B Underhill1, S J Green, P M Comoglio, G Tarone.   

Abstract

The cell surface receptor for hyaluronate is an integral membrane glycoprotein of Mr 85,000 (Underhill, C. B., Thurn, A. L., and Lacy, B. E. (1985) J. Biol. Chem. 260, 8128-8133), which appears to be associated with actin filaments. This protein is similar in many respects to another protein, termed gp85, which was originally identified by Tarone, G., Ferracini, R., Galeto, G., and Comoglio, P. (1984) J. Cell Biol. 99, 512-519), using a monoclonal antibody designated as K-3. The gp85 is also a membrane glycoprotein of Mr 85,000 which is associated with the cytoskeleton. Indeed, immunohistological staining has shown that it is distributed in patches along stress fibers of spread baby hamster kidney (BHK) cells. In the present study, we have used the K-3 monoclonal antibody to determine whether gp85 is identical to the hyaluronate receptor. Initial studies showed that the K-3 antibody reacted with material at Mr 85,000 on immunoblots of a purified preparation of the hyaluronate receptor. In addition, the K-3 antibody specifically blocked the binding of [3H]hyaluronate to detergent extracts of the receptor from both BHK and polyoma virus transformed baby hamster kidney (PY-BHK) cells, as well as to intact PY-BHK cells. These results indicate that the K-3 antibody is directed against the hyaluronate receptor, which therefore must be identical to gp85. The K-3 antibody was then used to determine the relative number of hyaluronate receptors associated with parent (BHK) and transformed (PY-BHK) cells. Using an enzyme-linked assay, we found that parent cells had a substantially greater number of receptors than their transformed counterparts. These results were consistent with those obtained when detergent extracts of cells were directly assayed for [3H]hyaluronate binding activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443488

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

Authors:  Ki Young Choi; Gurusamy Saravanakumar; Jae Hyung Park; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-20       Impact factor: 5.268

Review 2.  A pathological role for damaged hyaluronan in synovitis.

Authors:  E B Henderson; M Grootveld; A Farrell; E C Smith; P W Thompson; D R Blake
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

3.  Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding.

Authors:  R Hyman; J Lesley; R Schulte
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  Isolation and characterisation of antibodies which specifically recognise the peptide encoded by exon 7 (v2) of the human CD44 gene.

Authors:  A Borgya; A Woodman; M Sugiyama; F Donié; E Kopetzki; Y Matsumura; D Tarin
Journal:  Clin Mol Pathol       Date:  1995-10

Review 5.  The normal structure and function of CD44 and its role in neoplasia.

Authors:  R J Sneath; D C Mangham
Journal:  Mol Pathol       Date:  1998-08

6.  Release of hyaluronate from eukaryotic cells.

Authors:  P Prehm
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

Review 7.  CD44 and the adhesion of neoplastic cells.

Authors:  Z Rudzki; S Jothy
Journal:  Mol Pathol       Date:  1997-04

8.  Purification and characterization of a hyaluronan-binding protein from rat chondrosarcoma.

Authors:  M V Crossman; R M Mason
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

9.  Soluble CD44 in human ovarian follicular fluid.

Authors:  N Ohta; H Saito; T Kaneko; M Yoshida; T Takahashi; T Saito; K Nakahara; M Hiroi
Journal:  J Assist Reprod Genet       Date:  2001-01       Impact factor: 3.412

10.  Hyaluronate-binding proteins in weakly and highly metastatic variants of rat rhabdomyosarcoma cells.

Authors:  M Moczar; M F Poupon; E Moczar
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.